{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:12:59Z","timestamp":1792177979042,"version":"4.4.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.yebeh.2003.07.016","type":"journal-article","created":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:31:37Z","timestamp":1067646697000},"page":"757-760","source":"Crossref","is-referenced-by-count":53,"title":["Topiramate and status epilepticus: report of three cases"],"prefix":"10.1016","volume":"4","author":[{"given":"Meriem K.","family":"Bensalem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toufic A.","family":"Fakhoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2003.07.016_BIB1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1528-1157.1995.tb06004.x","article-title":"Pharmacokinetic properties of antiepileptic drugs","volume":"36","author":"Bourgeois","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2003.07.016_BIB2","first-page":"S11","article-title":"Pharmacokinetic properties of current antiepileptic drugs: what improvements are needed?","volume":"55","author":"Bourgeois","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2003.07.016_BIB3","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1111\/j.1528-1157.1997.tb04512.x","article-title":"Pharmacokinetics and interaction profile of topiramate: review and comparison with other newer antiepileptic drugs","volume":"38","author":"Johannessen","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2003.07.016_BIB4","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1177\/088307380001500106","article-title":"Pharmacokinetics and pharmacodynamics of topiramate","volume":"15","author":"Bourgeois","year":"2000","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.yebeh.2003.07.016_BIB5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0920-1211(90)90065-4","article-title":"A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus","volume":"5","author":"Treiman","year":"1990","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.yebeh.2003.07.016_BIB6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1468-1331.2002.00304.x","article-title":"Topiramate in drug-resistant complex partial status epilepticus","volume":"9","author":"Reuber","year":"2002","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.yebeh.2003.07.016_BIB7","first-page":"S241","article-title":"Rapid topiramate dose escalation in critically ill patients","volume":"43","author":"Rhoney","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2003.07.016_BIB8","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1212\/01.WNL.0000042783.86439.27","article-title":"The use of topiramate in refractory status epilepticus","volume":"60","author":"Towne","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2003.07.016_BIB9","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1001\/jama.249.11.1452","article-title":"Double-blind study of lorazepam and diazepam in status epilepticus","volume":"249","author":"Leppik","year":"1983","journal-title":"JAMA"},{"key":"10.1016\/j.yebeh.2003.07.016_BIB10","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0196-0644(05)80120-9","article-title":"Refractory status epilepticus in adults","volume":"22","author":"Jagoda","year":"1993","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.yebeh.2003.07.016_BIB11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archneur.59.2.205","article-title":"Refractory status epilepticus: frequency, risk factors and impact on outcome","volume":"59","author":"Mayer","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.yebeh.2003.07.016_BIB12","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/00003246-199307000-00004","article-title":"Advances in the management of refractory status epilepticus","volume":"21","author":"Bleck","year":"1993","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.yebeh.2003.07.016_BIB13","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1212\/WNL.43.3_Part_1.483","article-title":"Status epilepticus in an urban public hospital in the 1980s","volume":"43","author":"Lowenstein","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2003.07.016_BIB14","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM199809173391202","article-title":"A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group","volume":"339","author":"Treiman","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2003.07.016_BIB15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0006-8993(99)01615-7","article-title":"Topiramate reduces neuronal injury after experimental status epilepticus","volume":"837","author":"Niebauer","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.yebeh.2003.07.016_BIB16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0304-3940(00)00847-8","article-title":"Protective effect of topiramate against hippocampal neuronal damage after global ischemia in the gerbils","volume":"281","author":"Lee","year":"2000","journal-title":"Neurosci. Lett."},{"issue":"7","key":"10.1016\/j.yebeh.2003.07.016_BIB17","first-page":"S15","article-title":"Neuroprotective effects of topiramate in the kainic acid model of status epilepticus","volume":"43","author":"Cavazos","year":"2002","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.yebeh.2003.07.016_BIB18","first-page":"S15","article-title":"Topiramate is both neuroprotective and antiepileptogenic in the pilocarpine model of status epilepticus","volume":"43","author":"DeLorenzo","year":"2002","journal-title":"Epilepsia"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505003002087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505003002087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T08:54:03Z","timestamp":1550480043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505003002087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S1525505003002087"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2003.07.016","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}